Analysis
new
Racine
Analysis
new
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Lopinavir (therapeutic use) - Ritonavir (therapeutic use)

Terms

4Lopinavir (therapeutic use)
4Ritonavir (therapeutic use)
15Coronavirus Infections (drug therapy)
17Pneumonia, Viral (drug therapy)
15Antiviral Agents (therapeutic use)
8Betacoronavirus (drug effects)
4Antiviral Agents (pharmacology)
3Severe Acute Respiratory Syndrome (drug therapy)

Associations

Freq.WeightAssociation
41.000Lopinavir (therapeutic use) - Ritonavir (therapeutic use)
140.877Coronavirus Infections (drug therapy) - Pneumonia, Viral (drug therapy)
100.667Antiviral Agents (therapeutic use) - Coronavirus Infections (drug therapy)
90.564Antiviral Agents (therapeutic use) - Pneumonia, Viral (drug therapy)
60.548Betacoronavirus (drug effects) - Coronavirus Infections (drug therapy)
40.516Coronavirus Infections (drug therapy) - Ritonavir (therapeutic use)
40.516Coronavirus Infections (drug therapy) - Lopinavir (therapeutic use)
40.516Antiviral Agents (therapeutic use) - Ritonavir (therapeutic use)
40.516Antiviral Agents (therapeutic use) - Lopinavir (therapeutic use)
40.516Antiviral Agents (pharmacology) - Coronavirus Infections (drug therapy)
40.516Antiviral Agents (pharmacology) - Antiviral Agents (therapeutic use)
60.514Betacoronavirus (drug effects) - Pneumonia, Viral (drug therapy)
40.485Antiviral Agents (pharmacology) - Pneumonia, Viral (drug therapy)
30.420Pneumonia, Viral (drug therapy) - Severe Acute Respiratory Syndrome (drug therapy)
40.365Antiviral Agents (therapeutic use) - Betacoronavirus (drug effects)
30.364Pneumonia, Viral (drug therapy) - Ritonavir (therapeutic use)
30.364Lopinavir (therapeutic use) - Pneumonia, Viral (drug therapy)
Documents par ordre de pertinence
000014 (2020) H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine][Potential antiviral therapeutics for 2019 Novel Coronavirus].
000089 (2020) David CyranoskiThis scientist hopes to test coronavirus drugs on animals in locked-down Wuhan.
000194 (2020) Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine]Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
000280 (2020) Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie]Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
000427 (2020) Hongzhou Lu [République populaire de Chine]Drug treatment options for the 2019-new coronavirus (2019-nCoV).
000529 (2020) Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine]Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
000537 (2020) Ewen Callaway ; David CyranoskiChina coronavirus: Six questions scientists are asking.
000094 (2020) Guangdi Li ; Erik De ClercqTherapeutic options for the 2019 novel coronavirus (2019-nCoV).
000632 (2020) Eric J. Rubin ; Lindsey R. Baden ; Stephen MorrisseyAudio Interview: New Research on Possible Treatments for Covid-19.
000092 (2020) Robert L. Kruse [États-Unis]Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000312 (2020) Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis]Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
000428 (2020) Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash MedhiDrug targets for corona virus: A systematic review
000023 (2020) J P Zhao ; Y. Hu ; R H Du ; Z S Chen ; Y. Jin ; M. Zhou ; J. Zhang ; J M Qu ; B. Cao[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
000154 (2020) Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000342 (2020) Deng-Hai Zhang [République populaire de Chine] ; Kun-Lun Wu [République populaire de Chine] ; Xue Zhang [République populaire de Chine] ; Sheng-Qiong Deng [République populaire de Chine] ; Bin Peng [République populaire de Chine]In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus.
000007 (2020) X. Yuan [République populaire de Chine] ; J S Mu [République populaire de Chine] ; G X Mo [République populaire de Chine] ; X S Hu [République populaire de Chine] ; P. Yan [République populaire de Chine] ; L X Xie [République populaire de Chine][Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
000015 (2020) Y N Liu [République populaire de Chine][Pharmacotherapeutic about the new coronavirus pneumonia].
000027 (2020) L. Zhou [République populaire de Chine] ; H G Liu[Early detection and disease assessment of patients with novel coronavirus pneumonia].
000115 (2020) Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000255 (2020) G. Kampf [Allemagne] ; D. Todt [Allemagne] ; S. Pfaender [Allemagne] ; E. Steinmann [Allemagne]Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
000292 (2020) Fei Yu [République populaire de Chine] ; Lanying Du [États-Unis] ; David M. Ojcius [États-Unis] ; Chungen Pan [République populaire de Chine] ; Shibo Jiang [République populaire de Chine]Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.
000397 (2020) Heshui Shi ; Xiaoyu Han ; Chuansheng ZhengEvolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China.
000430 (2020) Shibo JiangDon't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
000445 (2020) Yaseen M. Arabi [Arabie saoudite] ; Robert Fowler [Canada] ; Frederick G. Hayden [États-Unis]Critical care management of adults with community-acquired severe respiratory viral infection
000662 (2020) Ying-Hui Jin [République populaire de Chine] ; Lin Cai [République populaire de Chine] ; Zhen-Shun Cheng [République populaire de Chine] ; Hong Cheng [République populaire de Chine] ; Tong Deng [République populaire de Chine] ; Yi-Pin Fan [République populaire de Chine] ; Cheng Fang [République populaire de Chine] ; Di Huang [République populaire de Chine] ; Lu-Qi Huang [République populaire de Chine] ; Qiao Huang [République populaire de Chine] ; Yong Han [République populaire de Chine] ; Bo Hu [République populaire de Chine] ; Fen Hu [République populaire de Chine] ; Bing-Hui Li [République populaire de Chine] ; Yi-Rong Li [République populaire de Chine] ; Ke Liang [République populaire de Chine] ; Li-Kai Lin [République populaire de Chine] ; Li-Sha Luo [République populaire de Chine] ; Jing Ma [République populaire de Chine] ; Lin-Lu Ma [République populaire de Chine] ; Zhi-Yong Peng [République populaire de Chine] ; Yun-Bao Pan [République populaire de Chine] ; Zhen-Yu Pan [République populaire de Chine] ; Xue-Qun Ren [République populaire de Chine] ; Hui-Min Sun [République populaire de Chine] ; Ying Wang [République populaire de Chine] ; Yun-Yun Wang [République populaire de Chine] ; Hong Weng [République populaire de Chine] ; Chao-Jie Wei [République populaire de Chine] ; Dong-Fang Wu [République populaire de Chine] ; Jian Xia [République populaire de Chine] ; Yong Xiong [République populaire de Chine] ; Hai-Bo Xu [République populaire de Chine] ; Xiao-Mei Yao [Canada] ; Yu-Feng Yuan [République populaire de Chine] ; Tai-Sheng Ye [République populaire de Chine] ; Xiao-Chun Zhang [République populaire de Chine] ; Ying-Wen Zhang [République populaire de Chine] ; Yin-Gao Zhang [République populaire de Chine] ; Hua-Min Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Ming-Juan Zhao [République populaire de Chine] ; Hao Zi [République populaire de Chine] ; Xian-Tao Zeng [République populaire de Chine] ; Yong-Yan Wang [République populaire de Chine] ; Xing-Huan Wang [République populaire de Chine]A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021